Suppression of experimental abdominal aortic aneurysms in the rat by treatment with angiotensin-converting enzyme inhibitors  Shixiong Liao, MSa, Manuel.

Slides:



Advertisements
Similar presentations
Nondissecting aneurysm of the thoracic aorta with arteritis in systemic lupus erythematosus  Hisato Takagi, MD, PhDa, Yoshio Mori, MD, PhDa, Hisashi Iwata,
Advertisements

Large renal artery aneurysm in Takayasu arteritis
Elastin, collagen, and some mechanical aspects of arterial aneurysms
Mesenchymal stem cells attenuate angiotensin II-induced aortic aneurysm growth in apolipoprotein E-deficient mice  Ryotaro Hashizume, MD, Aika Yamawaki-Ogata,
Naoki Fujimura, MD, PhD, Jiang Xiong, MD, PhD, Ellen B
Temporal changes in mouse aortic wall gene expression during the development of elastase-induced abdominal aortic aneurysms  Sarah J. Van Vickle-Chavez,
Accelerated aneurysmal dilation associated with apoptosis and inflammation in a newly developed calcium phosphate rodent abdominal aortic aneurysm model 
Castration of male mice prevents the progression of established angiotensin II-induced abdominal aortic aneurysms  Xuan Zhang, PhD, Sean Thatcher, PhD,
In vivo electroporation of constitutively expressed HIF-1α plasmid DNA improves neovascularization in a mouse model of limb ischemia  Geoffrey O. Ouma,
Elastic fibers reconstructed using adenovirus-mediated expression of tropoelastin and tested in the elastase model of abdominal aortic aneurysm in rats 
Simultaneous analysis of 1176 gene products in normal human aorta and abdominal aortic aneurysms using a membrane-based complementary DNA expression array 
Pharmacologic blockade and genetic deletion of androgen receptor attenuates aortic aneurysm formation  John P. Davis, MD, Morgan Salmon, PhD, Nicolas.
Endogenous superoxide dismutase activation by oral administration of riboflavin reduces abdominal aortic aneurysm formation in rats  Zhenhai Yu, MD, Keisuke.
Hyperglycemia limits experimental aortic aneurysm progression
Christopher K. Zarins, MD, Chengpei Xu, MD, Seymour Glagov, MD 
Rapid dilation of the abdominal aorta during infusion of angiotensin II detected by noninvasive high-frequency ultrasonography  Chiara Barisione, BSc,
Alexey V. Kamenskiy, PhD, Iraklis I. Pipinos, MD, PhD, Jeffrey S
Loss of STAT1 is associated with increased aortic rupture in an experimental model of aortic dissection and aneurysm formation  Matthew J. Eagleton, MD,
Tamoxifen up-regulates catalase production, inhibits vessel wall neutrophil infiltration, and attenuates development of experimental abdominal aortic.
Gorav Ailawadi, MD, Christopher W. Moehle, BS, Hong Pei, MD, Sandra P
Vascular smooth muscle cell peroxisome proliferator-activated receptor-γ deletion promotes abdominal aortic aneurysms  Milton Hamblin, PhD, Lin Chang,
Controlled release of ascorbic acid from gelatin hydrogel attenuates abdominal aortic aneurysm formation in rat experimental abdominal aortic aneurysm.
Mark Wengrovitz, MD. , Lulseged G. Selassie, MD. , Robert R. M
Suppression of experimental abdominal aortic aneurysms in mice by treatment with pyrrolidine dithiocarbamate, an antioxidant inhibitor of nuclear factor-κB 
Journal of Vascular Surgery
Indomethacin inhibits expansion of experimental aortic aneurysms via inhibition of the cox2 isoform of cyclooxygenase  Manuel Miralles, MD, William Wester,
Orally administered dipeptidyl peptidase-4 inhibitor (alogliptin) prevents abdominal aortic aneurysm formation through an antioxidant effect in rats 
Aortic aneurysms in children and young adults with tuberous sclerosis: Report of two cases and review of the literature  Corey J. Jost, MDa, Peter Gloviczki,
Asymptomatic internal carotid artery aneurysm
PC222. Loss of Normal Fiber Orientation in Human Abdominal Aortic Aneurysmal Tissue and Increased Energy Loss  Sandra Toth, BS, Doran Mix, MD, BS, Ibrahima.
Doxycycline inhibition of aneurysmal degeneration in an elastase-induced rat model of abdominal aortic aneurysm: Preservation of aortic elastin associated.
Pharmacologic suppression of experimental abdominal aortic aneurysms: A comparison of doxycycline and four chemically modified tetracyclines  John A.
New ascending aortic aneurysm model in rats reproduces main structural features of degenerative ascending thoracic aortic aneurysms in human beings  Narcis.
Monocyte chemotactic activity in human abdominal aortic aneurysms: Role of elastin degradation peptides and the 67–kD cell surface elastin receptor  Kirk.
Association of intraluminal thrombus in abdominal aortic aneurysm with local hypoxia and wall weakening  David A. Vorp, PhDa,b,c, Paul C. Lee, MDa, David.
Aneurysm formation in experimental atherosclerosis: Relationship to plaque evolution  Christopher K. Zarins, MD, Seymour Glagov, MD, Dragoslava Vesselinovitch,
Dennis R. Holmes, MD, William Wester, BA, Robert W
Elastase-induced matrix degradation in arterial organ cultures: An in vitro model of aneurysmal disease  Andrew Wills, BSc, Matthew M. Thompson, MD, FRCS,
Naoki Fujimura, Baohui Xu, Haojun Xuan, Jiang J
Nicolas H. Pope, MD, Morgan Salmon, PhD, William F
Cigarette smoking increases aortic dilatation without affecting matrix metalloproteinase- 9 and -12 expression in a modified mouse model of aneurysm formation 
Jing Wen, MD, Peiyi Wang, MS, Sumona V. Smith, MD, Carolyn A
Aortic aneurysm resulting from umbilical artery catheterization: Case report, literature review, and management algorithm  Jeffrey Mendeloff, MD,a, Anthony.
Doxycycline inhibits elastin degradation and reduces metalloproteinase activity in a model of aneurysmal disease  Jonathan R. Boyle, FRCS, Edward McDermott,
Harry M. Salinas, MD, Saiqa I. Khan, MD, Michael C
A novel rat model of abdominal aortic aneurysm using a combination of intraluminal elastase infusion and extraluminal calcium chloride exposure  Akiko.
Exploration of the mechanisms by which 3,4-benzopyrene promotes angiotensin II- induced abdominal aortic aneurysm formation in mice  Kangting Ji, MD, Yong.
Increased ICAM-1 expression in aortic disease
Significance of endoleaks after endovascular repair of abdominal aortic aneurysms: The EUROSTAR experience  Corine van Marrewijk, MSc, Jacob Buth, MD,
Nitric oxide inhibition increases matrix metalloproteinase–9 expression by rat aortic smooth muscle cells in vitro  Gilbert R. Upchurch, MD, John W. Ford,
Continuous periaortic infusion improves doxycycline efficacy in experimental aortic aneurysms  Eiketsu Sho, PhD, Jack Chu, PhD, Mien Sho, MD, Brian Fernandes,
Aortic Slimgraft: Ex vivo and in vivo study
Doxycycline in patients with abdominal aortic aneurysms and in mice: Comparison of serum levels and effect on aneurysm growth in mice  Amy K. Prall, BSa,
Lengthy suppression of vascular proliferation by a chymase inhibitor in dog grafted veins  Koutaro Tsunemi, MDa,b, Shinji Takai, PhDa, Masayoshi Nishimoto,
Transient exposure to elastase induces mouse aortic wall smooth muscle cell production of MCP-1 and RANTES during development of experimental aortic aneurysm 
Janet J. Chieh, BSa, Lucy S. Brevetti, MDb, Peter M
Boulos Toursarkissian, MD, David Schwartz, MD, PhD, Paul R
Immunosuppressive treatment of aortic allografts
The matrix metalloproteinase inhibitor BB-94 limits expansion of experimental abdominal aortic aneurysms  David A. Bigatel, MD, James R. Elmore, MD, David.
Folate supplementation inhibits intimal hyperplasia induced by a high-homocysteine diet in a rat carotid endarterectomy model  Todd P. Smith, MDa,b, Carlos.
Ruptured abdominal aortic aneurysm: A population-based study
Ramesh Lokanathan, MD, FRCS(C), David C. Taylor, MD, FRCS(C) 
Thoracoabdominal aortic aneurysm in Cogan’s syndrome
Journal of Vascular Surgery
Aneurysmal and occlusive atherosclerosis of the human abdominal aorta
Behçet's disease: Endovascular management of a ruptured peripheral arterial aneurysm  Karthikeshwar Kasirajan, MDa,b, John M. Marek, MDa, Mark Langsfeld,
Derek T. Woodrum, BS, Karl F. Welke, MD, Mark F. Fillinger, MD 
Wanfen Xiong, MD, PhD, Rebecca Knispel, BS, Jason Mactaggart, MD, B
The Propranolol Aneurysm Trial Investigators 
Cornelius A. Sullivan, MD, Michael J. Rohrer, MD, Bruce S. Cutler, MD 
Presentation transcript:

Suppression of experimental abdominal aortic aneurysms in the rat by treatment with angiotensin-converting enzyme inhibitors  Shixiong Liao, MSa, Manuel Miralles, MDa, Brian J. Kelley, BAa, John A. Curci, MDa, Martin Borhani, MDa, Robert W. Thompson, MDa, b, c  Journal of Vascular Surgery  Volume 33, Issue 5, Pages 1057-1064 (May 2001) DOI: 10.1067/mva.2001.112810 Copyright © 2001 Society for Vascular Surgery and The American Association for Vascular Surgery Terms and Conditions

Fig. 1 Development of elastase-induced abdominal aortic aneurysms in the rat. AD measurements after transient perfusion with either saline or elastase are expressed as percent increase between preperfusion and final AD. Each bar represents mean ± SEM for six rats. AAAs (horizontal line ) consistently developed within 7 days of elastase perfusion and were uniformly present by day 14. *P <.05 vs day 0, Student t test. Journal of Vascular Surgery 2001 33, 1057-1064DOI: (10.1067/mva.2001.112810) Copyright © 2001 Society for Vascular Surgery and The American Association for Vascular Surgery Terms and Conditions

Fig. 2 Effect of ACE inhibitors on the development of elastase-induced AAAs. Aneurysmal dilatation was assessed 14 days after elastase perfusion in animals treated with water alone or water supplemented with 250 mg/L of either captopril (CP ), lisinopril (LP ), enalapril (EP ), or losartan (LOS). Each bar represents mean ± SEM for six rats, with AAAs (horizontal line ). *P <.05, compared with water-treated controls. Journal of Vascular Surgery 2001 33, 1057-1064DOI: (10.1067/mva.2001.112810) Copyright © 2001 Society for Vascular Surgery and The American Association for Vascular Surgery Terms and Conditions

Fig. 3 Effect of ACE inhibitors on histology of elastase-induced AAAs. Transverse sections of formalin-fixed aortic tissue were stained with Verhoeff-van Gieson stain for elastin. a, Normal preperfusion aorta. b, Fourteen days after perfusion with saline, no aneurysmal dilatation. c, Fourteen days after perfusion with elastase, marked aneurysmal dilatation. d, Fourteen days after perfusion with elastase and captopril (CP ) treatment, no aneurysmal dilatation. Elastase-induced AAAs were associated with chronic inflammation and destruction of medial elastin (short arrows ). Treatment with ACE inhibitors was associated with preservation of elastic lamellae (long arrow ; original magnification, 100×). Journal of Vascular Surgery 2001 33, 1057-1064DOI: (10.1067/mva.2001.112810) Copyright © 2001 Society for Vascular Surgery and The American Association for Vascular Surgery Terms and Conditions

Fig. 4 Comparison of ACE inhibitors, aortic dilatation versus hemodynamic effects. Effects of different agents on elastase-induced aortic dilatation at day 14 are compared with their effects on mean arterial BP, with abdominal aortic aneurysms (AAA s) indicated (horizontal line ). There was no significant correlation demonstrated, r = 0.28), indicating that ACE inhibitors suppress aneurysmal degeneration by a mechanism(s) independent of their hemodynamic effects. Journal of Vascular Surgery 2001 33, 1057-1064DOI: (10.1067/mva.2001.112810) Copyright © 2001 Society for Vascular Surgery and The American Association for Vascular Surgery Terms and Conditions